Abstract
Introduction/Background* recent studies show that addition of anti-VEGF monoclonal antibody bevacizumab to platinum-based chemotherapy (P-CT) in advanced cervical cancer (ACC) treatment improves overall survival with an acceptable safety profile. The...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have